Cargando…

Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection

Objective: This study aims to determine expression of Glial Fibrillary Acidic Protein and of Alpha Smooth Muscle Actin (α-SMA) in hepatic stellate cells of CHC cases and their association with stage of fibrosis. Methods: The study was conducted at Ziauddin University, Clifton Campus during the year...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Sobia, Syed, Serajuddaula, Kehar, Shahnaz Imdad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publicaitons 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163226/
https://www.ncbi.nlm.nih.gov/pubmed/25225520
http://dx.doi.org/10.12669/pjms.305.5534
_version_ 1782334764287524864
author Hassan, Sobia
Syed, Serajuddaula
Kehar, Shahnaz Imdad
author_facet Hassan, Sobia
Syed, Serajuddaula
Kehar, Shahnaz Imdad
author_sort Hassan, Sobia
collection PubMed
description Objective: This study aims to determine expression of Glial Fibrillary Acidic Protein and of Alpha Smooth Muscle Actin (α-SMA) in hepatic stellate cells of CHC cases and their association with stage of fibrosis. Methods: The study was conducted at Ziauddin University, Clifton Campus during the year 2010-2012. Sixty Chronic Hepatitis C cases were immmunostained using anti α-SMA antibody and anti-GFAP antibody. Semi quantitative scoring in pericentral, periportal and perisinusoidal area of each case was done to assess immunoexpression of each marker. Results : Immunoexpression of GFAP showed significant association with α-SMA. GFAP expression was inversely correlated with progression of fibrosis. Conclusion : GFAP could represent a useful marker for early hepatic stellate cells activation. Follow up biopsies showing decline in GFAP levels may help identify the target group requiring aggressive therapy.
format Online
Article
Text
id pubmed-4163226
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Professional Medical Publicaitons
record_format MEDLINE/PubMed
spelling pubmed-41632262014-09-15 Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection Hassan, Sobia Syed, Serajuddaula Kehar, Shahnaz Imdad Pak J Med Sci Original Article Objective: This study aims to determine expression of Glial Fibrillary Acidic Protein and of Alpha Smooth Muscle Actin (α-SMA) in hepatic stellate cells of CHC cases and their association with stage of fibrosis. Methods: The study was conducted at Ziauddin University, Clifton Campus during the year 2010-2012. Sixty Chronic Hepatitis C cases were immmunostained using anti α-SMA antibody and anti-GFAP antibody. Semi quantitative scoring in pericentral, periportal and perisinusoidal area of each case was done to assess immunoexpression of each marker. Results : Immunoexpression of GFAP showed significant association with α-SMA. GFAP expression was inversely correlated with progression of fibrosis. Conclusion : GFAP could represent a useful marker for early hepatic stellate cells activation. Follow up biopsies showing decline in GFAP levels may help identify the target group requiring aggressive therapy. Professional Medical Publicaitons 2014 /pmc/articles/PMC4163226/ /pubmed/25225520 http://dx.doi.org/10.12669/pjms.305.5534 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hassan, Sobia
Syed, Serajuddaula
Kehar, Shahnaz Imdad
Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection
title Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection
title_full Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection
title_fullStr Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection
title_full_unstemmed Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection
title_short Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection
title_sort glial fibrillary acidic protein (gfap) as a mesenchymal marker of early hepatic stellate cells activation in liver fibrosis in chronic hepatitis c infection
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163226/
https://www.ncbi.nlm.nih.gov/pubmed/25225520
http://dx.doi.org/10.12669/pjms.305.5534
work_keys_str_mv AT hassansobia glialfibrillaryacidicproteingfapasamesenchymalmarkerofearlyhepaticstellatecellsactivationinliverfibrosisinchronichepatitiscinfection
AT syedserajuddaula glialfibrillaryacidicproteingfapasamesenchymalmarkerofearlyhepaticstellatecellsactivationinliverfibrosisinchronichepatitiscinfection
AT keharshahnazimdad glialfibrillaryacidicproteingfapasamesenchymalmarkerofearlyhepaticstellatecellsactivationinliverfibrosisinchronichepatitiscinfection